Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors

NCT04557449 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

362

Enrollment

INDUSTRY

Sponsor class

Conditions

Liposarcoma
Prostate Cancer
Breast Neoplasms
Adenocarcinoma of Lung

Interventions

DRUG: PF-07220060
COMBINATION_PRODUCT: Letrozole
COMBINATION_PRODUCT: Fulvestrant
DRUG: Midazolam
COMBINATION_PRODUCT: Enzalutamide

Sponsor

Pfizer